<DOC>
	<DOCNO>NCT01972932</DOCNO>
	<brief_summary>Antibiotic-associated diarrhea ( AAD ) particularly Clostridium difficile-Infection ( CDI ) common cause healthcare associate infectious diarrhea . In light result obtain limited number randomize clinical trial subject AAD CDI comparison widespread occurrence disease , felt addition well-controlled clinical trial western environment would add value support use specific probiotic counteract disease .</brief_summary>
	<brief_title>Study Bio-K+® Reduction Risk Clostridium Difficile Infection Antibiotic Associated Diarrhea</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>Inclusion Criteria Only subject meet follow inclusion criterion eligible participate study : Are least 18 year old Able tolerate food intake Antibiotic treatment start less 48hrs admission study Have expect hospitalization period least three day ( include subject‟s stay emergency room ) Speak understand English and/or French . Have expect survival great 60 day Agree refrain take probiotic product ( besides study drug ) study period Have give inform consent In addition , woman child bear capacity pregnant moment screening ( pregnancy test do onsite ) agree use acceptable form birth control duration study ( e.g . Condom , oral contraceptive , etc . ) allow participate . Exclusion Criteria Subjects meet follow exclusion criterion eligible participate study : Have diagnose CDI previous sixty day Have take Streptomycin , oral Vancomycin , Metronidazole last 4 week , exclude part treatment regimen trigger inclusion study . Are currently suffer health condition cause immunosuppression ( include haematological malignancy , lymphoma , AIDS , transplant , hemodialysis ) Have receive 10 mg prednisone per day least 1 month within 3 month prior participation study . Have active diarrhea ( three liquid stool per 24 hour period ) noncontrolled intestinal disease/colitis Crohn 's disease , ulcerative colitis caeliac disease Have stoma , ostomized parenteral nutrition user Have already randomize one arm study Are know show previous reaction , include anaphylaxis , substance composition study product ( i.e . Nonmedicinal ingredient : Cellulose , hypromellose , medium chain triglyceride , sodium alginate , ascorbic acid , magnesium stearate ( vegetal source ) , silicon dioxide titanium dioxide Where receive systemic antibiotic admission hospital treat antibiotic past two week Have lactose intolerance milk allergy Have difficulty give informed consent chronic mental disease , dementia Are likely comply study requirement ( provide stool screen diarrhea answer follow questionnaire ) Have know use illicit drug last two year . Have participate another clinical study last 30 day Female subject pregnant , intend become pregnant lactate study period Female subject child bear potential currently use adequate contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Bio-K+®</keyword>
	<keyword>Placebo</keyword>
	<keyword>AAD</keyword>
	<keyword>CDI</keyword>
	<keyword>hospitalize subject</keyword>
</DOC>